Dr. Vijay K. Ramanan discusses his paper, "Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging". <p>Show references: https://n.neurology.org/content/early/2023/08/16/WNL.0000000000207770</p>

Dr. Vijay K. Ramanan discusses his paper, "Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging". Show references: https://n.neurology.org/content/early/2023/08/16/WNL.0000000000207770

Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging

The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.

Share Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging

Sign up to save your podcasts

Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging

Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging

More shows like Neurology Minute

JAMA Clinical Reviews

Neurology® Podcast

Practical Neurology Podcast

Mayo Clinic Talks

The Curbsiders Internal Medicine Podcast

Emergency Medical Minute

JAMA Neurology Author Interviews

Neurology Today in 5

Annals On Call Podcast

The Clinical Problem Solvers

Harrison's PodClass: Internal Medicine Cases and Board Prep

Short Wave

Neurology Exam Prep Podcast

The Curious Clinicians

Continuum Audio